IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 20 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,922,620 | -1.7% | 40,200,000 | 0.0% | 0.18% | -10.4% |
| Q2 2023 | $40,617,120 | +24.6% | 40,200,000 | +24.8% | 0.20% | +21.8% |
| Q1 2023 | $32,589,833 | +33.2% | 32,200,000 | +41.9% | 0.16% | -7.3% |
| Q4 2022 | $24,473,438 | +6.8% | 22,700,000 | 0.0% | 0.18% | +29.0% |
| Q3 2022 | $22,913,000 | +22.7% | 22,700,000 | +28.2% | 0.14% | +51.6% |
| Q2 2022 | $18,674,000 | +27.7% | 17,700,000 | +39.4% | 0.09% | +127.5% |
| Q1 2022 | $14,624,000 | +34.5% | 12,700,000 | +30.9% | 0.04% | +122.2% |
| Q4 2021 | $10,870,000 | -5.4% | 9,700,000 | 0.0% | 0.02% | -21.7% |
| Q3 2021 | $11,487,000 | -0.1% | 9,700,000 | 0.0% | 0.02% | -11.5% |
| Q2 2021 | $11,504,000 | +29.8% | 9,700,000 | +21.2% | 0.03% | 0.0% |
| Q1 2021 | $8,865,000 | -1.1% | 8,000,000 | 0.0% | 0.03% | -13.3% |
| Q4 2020 | $8,964,000 | -18.6% | 8,000,000 | -27.3% | 0.03% | -46.4% |
| Q3 2020 | $11,006,000 | – | 11,000,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 5,300,000 | $6,265,000 | 0.59% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,457,000 | $5,272,000 | 0.40% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 10,416,000 | $12,314,000 | 0.28% |
| AQR Arbitrage LLC | 7,700,000 | $9,119,000 | 0.26% |
| WOLVERINE ASSET MANAGEMENT LLC | 21,227,000 | $25,018,000 | 0.22% |
| LINDEN ADVISORS LP | 26,849,000 | $31,752,000 | 0.19% |
| HBK INVESTMENTS L P | 10,000,000 | $11,822,000 | 0.05% |
| Calamos Advisors LLC | 7,500,000 | $8,910,000 | 0.04% |
| Jefferies Group LLC | 3,245,000 | $3,856,677 | 0.03% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 9,700,000 | $11,487,000 | 0.02% |